ArticleAmerican journal of respiratory and critical care medicine2017

Reply: Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

Ulrich Costabel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.